Search preferences
Skip to main search results

Search filters

Product Type

  • All Product Types 
  • Books (4)
  • Magazines & Periodicals (No further results match this refinement)
  • Comics (No further results match this refinement)
  • Sheet Music (No further results match this refinement)
  • Art, Prints & Posters (No further results match this refinement)
  • Photographs (No further results match this refinement)
  • Maps (No further results match this refinement)
  • Manuscripts & Paper Collectibles (No further results match this refinement)

Condition Learn more

  • New (4)
  • As New, Fine or Near Fine (No further results match this refinement)
  • Very Good or Good (No further results match this refinement)
  • Fair or Poor (No further results match this refinement)
  • As Described (No further results match this refinement)

Binding

Collectible Attributes

  • First Edition (4)
  • Signed (No further results match this refinement)
  • Dust Jacket (No further results match this refinement)
  • Seller-Supplied Images (No further results match this refinement)
  • Not Print on Demand (4)

Language (1)

Price

  • Any Price 
  • Under £ 20 (No further results match this refinement)
  • £ 20 to £ 40 (No further results match this refinement)
  • Over £ 40 
Custom price range (£)

Seller Location

  • Evan B. Siegel

    Language: English

    Published by John Wiley & Sons Inc, Hoboken, 2008

    ISBN 10: 0470050942 ISBN 13: 9780470050941

    Seller: Grand Eagle Retail, Bensenville, IL, U.S.A.

    Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

    Contact seller

    First Edition

    £ 105.99

    Free Shipping
    Ships within U.S.A.

    Quantity: 1 available

    Add to basket

    Hardcover. Condition: new. Hardcover. A step-by-step, integrated approach for successful, FDA-approved combination drug products Using a proven integrated approach to combination drug development, this book guides you step by step through all the preclinical, clinical, and manufacturing stages. Written from an FDA regulatory perspective, the book not only enables you to bring a successful combination drug product to market, it also sets forth the most efficient and effective path to FDA approval. The book begins with an introductory chapter presenting definitions and basic regulatory principles of combination products. Next, it reviews manufacturing and controls, preclinical testing models, pharmacology, clinical testing, regulatory submissions, FDA reviews, and approvals. Among the key topics examined are: * The pharmacology, safety pharmacology, and toxicology supporting human clinical trials of combination products * Approaches to clinical trial protocol design and execution * Chemical, physicochemical, and analytical aspects of manufacturing controls and validation that lead to stable components for combination products * Key sponsor/FDA meetings and negotiations essential for approval and commercialization Case studies involving such actual combination products as Mylotarg, Herceptin, and HercepTest help you better understand how to implement the author's practical guidelines. References at the end of each chapter enable you to find more information on any stage of the development, manufacturing and approval processes. This book is ideal for researchers, regulators, academics, project managers, and executives involved in the complex process of combination product development. Not only does itoffer a comprehensive guide to the technical aspects of the field, it also integrates all ofthese technical aspects into a unified, effective approach to help ensure a successful, approved product. A step-by-step, integrated approach for successful, FDA-approved combination drug products Using a proven integrated approach to combination drug development, this book guides you step by step through all the preclinical, clinical, and manufacturing stages. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

  • Siegel, Evan B.

    Language: English

    Published by John Wiley & Sons Inc, 2008

    ISBN 10: 0470050942 ISBN 13: 9780470050941

    Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland

    Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

    Contact seller

    First Edition

    £ 121.06

    £ 9.10 shipping
    Ships from Ireland to U.S.A.

    Quantity: Over 20 available

    Add to basket

    Condition: New. A step-by-step, integrated approach for successful, FDA-approved combination drug products Using a proven integrated approach to combination drug development, this book guides you step by step through all the preclinical, clinical, and manufacturing stages. Editor(s): Siegel, Evan B. Num Pages: 216 pages, Illustrations. BIC Classification: MMG; TCB; TDCW. Category: (P) Professional & Vocational. Dimension: 239 x 161 x 19. Weight in Grams: 514. . 2008. 1st Edition. Hardcover. . . . .

  • Evan B. Siegel

    Language: English

    Published by John Wiley & Sons Inc, Hoboken, 2008

    ISBN 10: 0470050942 ISBN 13: 9780470050941

    Seller: CitiRetail, Stevenage, United Kingdom

    Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

    Contact seller

    First Edition

    £ 97.49

    £ 37 shipping
    Ships from United Kingdom to U.S.A.

    Quantity: 1 available

    Add to basket

    Hardcover. Condition: new. Hardcover. A step-by-step, integrated approach for successful, FDA-approved combination drug products Using a proven integrated approach to combination drug development, this book guides you step by step through all the preclinical, clinical, and manufacturing stages. Written from an FDA regulatory perspective, the book not only enables you to bring a successful combination drug product to market, it also sets forth the most efficient and effective path to FDA approval. The book begins with an introductory chapter presenting definitions and basic regulatory principles of combination products. Next, it reviews manufacturing and controls, preclinical testing models, pharmacology, clinical testing, regulatory submissions, FDA reviews, and approvals. Among the key topics examined are: * The pharmacology, safety pharmacology, and toxicology supporting human clinical trials of combination products * Approaches to clinical trial protocol design and execution * Chemical, physicochemical, and analytical aspects of manufacturing controls and validation that lead to stable components for combination products * Key sponsor/FDA meetings and negotiations essential for approval and commercialization Case studies involving such actual combination products as Mylotarg, Herceptin, and HercepTest help you better understand how to implement the author's practical guidelines. References at the end of each chapter enable you to find more information on any stage of the development, manufacturing and approval processes. This book is ideal for researchers, regulators, academics, project managers, and executives involved in the complex process of combination product development. Not only does itoffer a comprehensive guide to the technical aspects of the field, it also integrates all ofthese technical aspects into a unified, effective approach to help ensure a successful, approved product. A step-by-step, integrated approach for successful, FDA-approved combination drug products Using a proven integrated approach to combination drug development, this book guides you step by step through all the preclinical, clinical, and manufacturing stages. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.

  • Evan B. Siegel

    Language: English

    Published by John Wiley & Sons Inc, Hoboken, 2008

    ISBN 10: 0470050942 ISBN 13: 9780470050941

    Seller: AussieBookSeller, Truganina, VIC, Australia

    Seller rating 5 out of 5 stars 5-star rating, Learn more about seller ratings

    Contact seller

    First Edition

    £ 155.49

    £ 27.75 shipping
    Ships from Australia to U.S.A.

    Quantity: 1 available

    Add to basket

    Hardcover. Condition: new. Hardcover. A step-by-step, integrated approach for successful, FDA-approved combination drug products Using a proven integrated approach to combination drug development, this book guides you step by step through all the preclinical, clinical, and manufacturing stages. Written from an FDA regulatory perspective, the book not only enables you to bring a successful combination drug product to market, it also sets forth the most efficient and effective path to FDA approval. The book begins with an introductory chapter presenting definitions and basic regulatory principles of combination products. Next, it reviews manufacturing and controls, preclinical testing models, pharmacology, clinical testing, regulatory submissions, FDA reviews, and approvals. Among the key topics examined are: * The pharmacology, safety pharmacology, and toxicology supporting human clinical trials of combination products * Approaches to clinical trial protocol design and execution * Chemical, physicochemical, and analytical aspects of manufacturing controls and validation that lead to stable components for combination products * Key sponsor/FDA meetings and negotiations essential for approval and commercialization Case studies involving such actual combination products as Mylotarg, Herceptin, and HercepTest help you better understand how to implement the author's practical guidelines. References at the end of each chapter enable you to find more information on any stage of the development, manufacturing and approval processes. This book is ideal for researchers, regulators, academics, project managers, and executives involved in the complex process of combination product development. Not only does itoffer a comprehensive guide to the technical aspects of the field, it also integrates all ofthese technical aspects into a unified, effective approach to help ensure a successful, approved product. A step-by-step, integrated approach for successful, FDA-approved combination drug products Using a proven integrated approach to combination drug development, this book guides you step by step through all the preclinical, clinical, and manufacturing stages. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.